Related Experiment Video
Updated: Jun 3, 2026
10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Establishing a knowledge trail from molecular experiments to clinical trials.
May Yee Yong1, Alejandra González-Beltrán, Richard Begent
1UCL Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London WC1E 6BT, UK. m.yong@ucl.ac.uk
New Biotechnology
|April 9, 2011
Summary
A new guideline standardizes antibody therapy experiment reporting to prevent data misuse. This ensures consistent data interpretation across research teams and models, reducing risks in drug development.
Area of Science:
- Biotechnology
- Pharmacology
- Immunology
Background:
- Antibody therapy development involves sequential testing across diverse biological models.
- Interpreting experimental data can be challenging due to inconsistent recording and ambiguous terminology.
- Lack of clear data provenance risks misinterpretation and misuse, introducing risks in therapy development.
Purpose of the Study:
- To establish a standardized reporting guideline for antibody therapy experiments.
- To improve data consistency and clarity across different research models and teams.
- To mitigate risks associated with data misinterpretation in antibody therapy development.
Main Methods:
- Development of a comprehensive checklist for recording experimental data.
- Guideline application across molecular, cellular, animal, and clinical models.
- Focus on clear terminology and consistent data recording practices.
Main Results:
- A structured reporting guideline has been created for antibody therapy experiments.
- The guideline facilitates consistent data recording and interpretation.
- Potential for reduced risk and enhanced data integrity in drug development.
Conclusions:
- Standardized reporting is crucial for reliable antibody therapy development.
- The developed guideline enhances data consistency and reduces misinterpretation risks.
- Implementation of this guideline supports safer and more efficient therapeutic agent progression.
More Related Videos
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:13Data Collection by Experiments
Data collection is a systematic method of obtaining, observing, measuring, and analyzing accurate information. An experimental study is a standard method of data collection that involves the manipulation of the samples by applying some form of treatment prior to data collection. It refers to manipulating one variable to determine its changes on another variable. The sample subjected to treatment is known as “experimental units.”
An example of the experimental method is a public clinical trial...
An example of the experimental method is a public clinical trial...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...